Pediatric allo-SCT for malignant and non-malignant diseases: Impact on health-related quality of life outcomes

Bone Marrow Transplantation

Volumn 48, Issue 6, 2013, Pages 787-793

  Oberg, J A ^a   Bender, J G ^a   Morris, E ^b   Harrison, L ^b   Basch, C E ^c   Garvin, J H ^a   Sands, S A ^a   Cairo, M S ^d  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c Columbia University ^*  (United States)

^d WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

allo SCT; pediatric; quality of life

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; MELPHALAN;

ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL EFFECTIVENESS; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMOTIONALITY; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOVEMENT (PHYSIOLOGY); MUSCLE STRENGTH; PAIN; PHYSICAL CAPACITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SCHOOL CHILD; SELF REPORT; SOCIAL INTERACTION;

ADOLESCENT; ADULT; AGE FACTORS; ALLOGRAFTS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; EMOTIONS; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HUMANS; MALE; NEOPLASMS; QUALITY OF LIFE; SOCIAL BEHAVIOR; STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING; UNRELATED DONORS;

EID: 84879108970     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.217     Document Type: Conference Paper

References (57)

1. Biagas K, Bradley MB, Cairo MS. Bone marrow and stem cell transplantation. In: Nichols DG (ed.). Rogers Textbook of Pediatric Intensive Care, 4th edn. Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2008, pp 1759-1778.
2. Bollard CM, Krance RA, Heslop HE. Hematopoietic stem cell transplantation in pediatric oncology. In: Pizzo PA, Poplack DG (eds). Principles and Practice of Pediatric Oncology, 5th edn. Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2006, pp 476-500.
3. Santos GW. History of bone marrow transplantation. Clin Haematol 1983; 12: 611-639.
4. Sullivan KM. Long-term results of allogeneic bone marrow transplantation. Transplant Proc 1989; 21(1 Part 3): 2926-2928.
5. Satwani P, Cooper N, Rao K, Veys P, Amrolia P. Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases. Bone Marrow Transplant 2008; 41: 173-182.
6. Satwani P, Morris E, Bradley MB, Bhatia M, van de Ven C, Cairo MS. Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseases. Pediatr Blood Cancer 2008; 50: 1-8.
7. Geyer MB, Jacobson JS, Freedman J, George D, Moore V, van de Ven C et al. A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients. Br J Haematol 2011; 155: 218-234.
8. Satwani P, Bavishi S, Jin Z, Jacobson JS, Baker C, Duffy D et al. Risk factors associated with kidney injury and the impact of kidney injury on overall survival in pediatric recipients following allogeneic stem cell transplant. Biol Blood Marrow Transplant 2011; 17: 1472-1480.
9. Satwani P, Harrison L, Morris E, Del Toro G, Cairo MS. Reduced-intensity allogeneic stem cell transplantation in adults and children with malignant and nonmalignant diseases: end of the beginning and future challenges. Biol Blood Marrow Transplant 2005; 11: 403-422.
10. Parsons SK, Barlow SE, Levy SL, Supran SE, Kaplan SH. Health-related quality of life in pediatric bone marrow transplant survivors: according to whom? Int J Cancer Suppl 1999; 83: 46-51.
11. Parsons SK, Shih M, DuHamel KN, Ostroff J, Mayer DK, Austin J. Maternal perspectives on children's health related quality of life during the first year after pediatric hematopoietic stem cell transplant. J Pediatr Psychol 2006; 31: 1100-1115.
12. Barrera M, Atenafu E, Pinto J. Behavioral, social, and educational outcomes after pediatric stem cell transplantation and related factors. Cancer 2009; 115: 880-889.
13. Duell T, van Lint MT, Ljungman P, Tichelli A, Socie G, Apperley JF et al. Health and functional status of long-term survivors of bone marrow transplantation. Ann Intern Med 1997; 126: 184-192.
14. Ness KK, Bhatia S, Baker KS, Francisco L, Carter A, Forman SJ et al. Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation: the bone marrow transplant survivor study. Arch Pediatr Adolesc Med 2005; 159: 706-713.
15. Hovi L, Kurimo M, Taskinen M, Vettenranta J, Vettenranta K, Saarinen-Pihkala UM. Suboptimal long-term physical performance in children and young adults after pediatric allo-SCT. Bone Marrow Transplant 2010; 45: 738-745.
16. Fraser CJ, Bhatia S, Ness K, Carter A, Francisco L, Arora M et al. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the bone marrow transplant survivor study. Blood 2006; 108: 2867-2873.
17. Sanders JE, Hoffmeister PA, Storer BE, Appelbaum FR, Storb RF, Syrjala KL. The quality of life of adult survivors of childhood hematopoietic cell transplant. Bone Marrow Transplant 2010; 45: 746-754.
18. Andrykowski MA. Psychosocial factors in bone marrow transplantation: a review and recommendations for research. Bone Marrow Transplant 1994; 13: 357-375.
19. Hjermstad M, Loge JH, Evensen SA, Kvaloy SO, Fayers PM, Kaasa S. The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation. Bone Marrow Transplant 1999; 24: 1219-1228.
20. Leigh S, Wilson KCM, Burns R, Clark RE. Psychosocial morbidity in bone marrow transplant recipients: a prospective study. Bone Marrow Transplant 1995; 16: 635-640.
21. McQuellon RP, Russell GB, Rambo TD, Craven BL, Radford J, Perry JJ. Quality of life and psychological distress of bone marrow transplant recipients: the 'time trajectory' to recovery over the first year. Bone Marrow Transplant 1998; 21: 477-486.
22. Sasaki T, Akaho R, Sakamaki H, Akiyama H, Yoshino M, Hagiya K et al. Mental disturbances during isolation in bone marrow transplant patients with leukemia. Bone Marrow Transplant 2000; 25: 315-318.
23. Phipps S, Dunavant M, Lensing S, Rai SN. Acute health-related quality of life in children undergoing stem cell transplant: II. Medical and demographic determinants. Bone Marrow Transplant 2002; 29: 435-442.
24. Phipps S, Dunavant M, Garving PA, Lensing S, Rai SN. Acute health related quality of life in children undergoing stem cell transplant: I. Descriptive outcomes. Bone Marrow Transplant 2002; 29: 425-434.
25. Badell I, Igual L, Gomez P, Bureo E, Ortega JJ, Cubells J et al. Quality of life in young adults having received a BMT during childhood: a GETMON study. Bone Marrow Transplant 1998; 21(Suppl. 2): 68-71.
26. Helder DI, Bakker B, de Heer P, van der Veen F, Vossen J, Wit JM et al. Quality of life in adults following bone marrow transplantation during childhood. Bone Marrow Transplant 2004; 33: 329-336.
27. Matthes-Martin S, Lamche M, Ladenstein R, Emminger W, Felsberger C, Topf R et al. Organ toxicity and quality of life after allogeneic bone marrow transplantation in pediatric patients: a single centre retrospective analysis. Bone Marrow Transplant 1999; 23: 1049-1053.
28. Felder-Puig R, Peters C, Matthes-Martin S, Lamche M, Felsberger C, Gadner H. Psychosocial adjustment of pediatric patients after allogeneic stem cell transplantation. Bone Marrow Transplant 1999; 24: 75-80.
29. Nespoli L, Verri AP, Locatelli F, Bertuggia L, Taibi RM, Burglo GR. The impact of paediatric bone marrow transplantation on quality of life. Qual Life Res 1995; 4: 233-240.
30. Bhatia M, Militano O, Jin Z, Figurski M, Shaw L, Moore V et al. An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients. Biol Blood Marrow Transplant 2010; 16: 333-343.
31. Osunkwo I, Bessmertny O, Harrison L, Cheung Y, Van De Ven C, del Toro G et al. A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients. Biol Blood Marrow Transplant 2004; 10: 246-258.
32. Glucksberg H, Storb R, Fefer A, Buckner C, Neiman P, Clift R et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLAmatched sibling donors. Transplantation 1974; 18: 295-304.
33. Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL in pediatric cancer: reliability and validity of the pediatric quality of life inventory generic core scales, multidimensional fatigue scale, and cancer module. Cancer 2002; 94: 2090-2106.
34. Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr 2003; 3: 329-341.
35. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations. Med Care 2001; 39: 800-812.
36. Caocci G, Efficace F, Ciotti F, Roncarolo MG, Vacca A, Piras E et al. Prospective assessment of health-related quality of life in pediatric patients with betathalassemia following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011; 17: 861-866.
37. Cheuk DK, Mok AS, Lee AC, Chiang AK, Ha SY, Lau YL et al. Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT. Bone Marrow Transplant 2008; 42: 319-327.
38. Felder-Puig R, di Gallo A, Waldenmair M, Norden P, Winter A, Gadner H et al. Health-related quality of life of pediatric patients receiving allogeneic stem cell or bone marrow transplantation: results of a longitudinal, multi-center study. Bone Marrow Transplant 2006; 38: 119-126.
39. Nuss SL, Wilson ME. Health-related quality of life following hematopoietic stem cell transplant during childhood. J Pediatr Oncol Nurs 2007; 24: 106-115.
40. Uygun V, Tayfun F, Akcan M, Karasu GT, Kupesiz A, Hazar V et al. Quality of life assessment in hematopoietic stem cell transplantation performed on thalassemia major patients. Pediatr Hematol Oncol 2012; 29: 461-471.
41. Varni JW, Thompson KL, Hanson V. The Varni/Thompson pediatric pain questionnaire. I. Chronic musculoskeletal pain in juvenile rheumatoid arthritis. Pain 1987; 28: 27-38.
42. Varni JW, Waldron SA, Gragg RA, Rapoff MA, Bernstein BH, Lindsley CB et al. Development of the Waldron/Varni pediatric pain coping inventory. Pain 1996; 67: 141-150.
43. Raudenbush S, Bryk A, Cheong YF, Congdon R, du Toit M. HLM 6: Hierarchical Linear and Nonlinear Modeling. Scientific Software International, Inc.: Lincolnwood, 2004.
44. Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2 edn. Lawrence Earlbaum Associates: Hillsdale, NJ, USA, 1998.
45. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991; 59: 12-19.
46. Wyrwich KW, Wolinsky FD. Identifying meaningful intra-individual change standards for health-related quality of life measures. J Eval Clin Prac 2000; 6: 39-49.
47. Ferguson RJ, Robinson AB, Splaine M. Use of the reliable change index to evaluate clinical significance in SF-36 outcomes. Qual Life Res 2002; 11: 509-516.
48. Bryk AS, Raudenbush SW. Hierarchical Linear Models: Applications and Data Analysis Methods. Sage: Newbury Park, CA, USA, 1992.
49. Gibbons RD, Hedeker D, Elkin I, Watermaux C, Kraemer HC, Greenhouse JB et al. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. application to the NIMH treatment of Depression Collaborative Research Program dataset. Arch Gen Psychiatry 1993; 50: 739-750.
50. Willett JB. Measuring change: what individual growth modeling buys you. In: Arnsel E, Reninger KA (eds). Change and Development. Erlbaum: Maywah, NJ, USA, 1997, pp 213-243.
51. Feingold A. Effect sizes for growth-modeling analysis for controlled clinical trials in the same metric as for classical analysis. Psychol Methods 2009; 14: 43-53.
52. Raudenbush SW, Xiao-Feng L. Effects of study duration, frequency of observation, and sample size on power in studies of group differences in polynomial change. Psychol Methods 2001; 6: 387-401.
53. Shone LP, Dick AW, Klein JD, Zwanziger J, Szilagyi PG. Reduction in racial and ethnic disparities after enrollment in the State Children's Health Insurance Program. Pediatrics 2005; 115: e697-e705.
54. Andersson I, Ahlberg K, Stockelberg D, Brune M, Persson LO. Health-related quality of life in patients undergoing allogeneic stem cell transplantation after reduced intensity conditioning versus myeloablative conditioning. Cancer Nurs 2009; 32: 325-334.
55. Gupta V, Panzarella T, Li L, Khan J, Sharma A, Lipton JH et al. A prospective study comparing the outcomes and health-related quality of life in adult patients with myeloid malignancies undergoing allogeneic transplantation using myeloablative or reduced-intensity conditioning. Biol Blood Marrow Transplant 2012; 18: 113-124.
56. Barrera M, Atenafu E, Hancock K. Longitudinal health-related quality of life outcomes and related factors after pediatric SCT. Bone Marrow Transplant 2009; 44: 249-256.
57. Forinder U, Lof C, Winiarski J. Quality of life following allogeneic stem cell transplantation, comparing parents' and childrens' perspective. Pediatr Transplant 2006; 10: 491-496.